BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32421102)

  • 1. Exploring the active compounds of traditional Mongolian medicine in intervention of novel coronavirus (COVID-19) based on molecular docking method.
    Yu JW; Wang L; Bao LD
    J Funct Foods; 2020 Aug; 71():104016. PubMed ID: 32421102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacological mechanism of Huashi Baidu Formula for the treatment of COVID-19 by combined network pharmacology and molecular docking.
    Cai Y; Zeng M; Chen YZ
    Ann Palliat Med; 2021 Apr; 10(4):3864-3895. PubMed ID: 33691446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between piperine and genes associated with sciatica and its mechanism based on molecular docking technology and network pharmacology.
    Yu JW; Yuan HW; Bao LD; Si LG
    Mol Divers; 2021 Feb; 25(1):233-248. PubMed ID: 32130644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Material Basis of Yupingfeng Powder for the Prevention and Treatment of 2019 Novel Coronavirus Pneumonia: A Study Involving Molecular Docking and Molecular Dynamic Simulation Technology.
    Yu Y; Zhang G; Han T; Liu H; Huang H
    Biomed Res Int; 2022; 2022():7892397. PubMed ID: 35782070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular dynamics simulation study of the ACE2 receptor with screened natural inhibitors to identify novel drug candidate against COVID-19.
    Srivastava N; Garg P; Srivastava P; Seth PK
    PeerJ; 2021; 9():e11171. PubMed ID: 33981493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential common mechanism of four Chinese patent medicines recommended by diagnosis and treatment protocol for COVID-19 in medical observation period.
    Wang L; Wang Z; Yang Z; Wang X; Yan L; Wu J; Liu Y; Fu B; Yang H
    Front Med (Lausanne); 2022; 9():874611. PubMed ID: 36388945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Homologous modeling and binding ability analysis of Spike protein after point mutation of severe acute respiratory syndrome coronavirus 2 to receptor proteins and potential antiviral drugs].
    Cao Z; Wang LT; Liu ZM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 53(1):150-158. PubMed ID: 33550350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the mechanism of action of Xuanfei Baidu granule (XFBD) in the treatment of COVID-19 based on molecular docking and molecular dynamics.
    Xiong L; Cao J; Yang X; Chen S; Wu M; Wang C; Xu H; Chen Y; Zhang R; Hu X; Chen T; Tang J; Deng Q; Li D; Yang Z; Xiao G; Zhang X
    Front Cell Infect Microbiol; 2022; 12():965273. PubMed ID: 36034710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Bioactive Components of Nine TCM Prescriptions Against COVID-19 in Lung Cancer Were Explored Based on Network Pharmacology and Molecular Docking.
    Du L; Xiao Y; Xu Y; Chen F; Chu X; Cao Y; Zhang X
    Front Med (Lausanne); 2021; 8():813119. PubMed ID: 35127768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy.
    Wei TZ; Wang H; Wu XQ; Lu Y; Guan SH; Dong FQ; Dong CL; Zhu GL; Bao YZ; Zhang J; Wang GY; Li HY
    Chin J Integr Med; 2020 Sep; 26(9):663-669. PubMed ID: 32740825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Cyanobacteria-Based Natural Inhibitors Against SARS-CoV-2 Druggable Target ACE2 Using Molecular Docking Study, ADME and Toxicity Analysis.
    Sahu N; Mishra S; Kesheri M; Kanchan S; Sinha RP
    Indian J Clin Biochem; 2023 Jul; 38(3):361-373. PubMed ID: 35812791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19: docking-based virtual screening and molecular dynamics study to identify potential SARS-CoV-2 spike protein inhibitors from plant-based phenolic compounds.
    Moradkhani S; Farmani A; Saidijam M; Taherkhani A
    Acta Virol; 2021; 65(3):288-302. PubMed ID: 34565157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies.
    Zhang S; Gao C; Das T; Luo S; Tang H; Yao X; Cho CY; Lv J; Maravillas K; Jones V; Chen X; Huang R
    J Immunol Methods; 2022 Apr; 503():113244. PubMed ID: 35218866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation.
    Gorla US; Rao K; Kulandaivelu US; Alavala RR; Panda SP
    Comb Chem High Throughput Screen; 2021; 24(6):879-890. PubMed ID: 32819226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Modeling Targeting the ACE2 Receptor with
    El Ouafi Z; Rhalem W; Habib N; Idrissi Azami A; Sehli S; Al Idrissi N; Bakkali F; Abderrazak R; Merzouki M; Allali I; Amzazi S; Nejjari C; Ghazal H
    Bioinform Biol Insights; 2022; 16():11779322221145380. PubMed ID: 36582392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Material basis and mechanism of Xiao'er Resuqing Oral Liquid on hand, foot and mouth disease based on network pharmacology and molecular docking].
    Xu YL; Guo SS; Cui XL; Shi YJ
    Zhongguo Zhong Yao Za Zhi; 2020 Dec; 45(23):5745-5752. PubMed ID: 33496115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for drug repurposing to study the interface of the S protein in SARS-CoV-2 and human ACE2 through docking, characterization, and molecular dynamics for natural drug candidates.
    Alazmi M; Motwalli O
    J Mol Model; 2020 Nov; 26(12):338. PubMed ID: 33175236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on potential molecular mechanism of Mongolian medicine Bawei Sanxiang San in treatment of chronic heart failure based on network pharmacology and molecular docking].
    Bai YL; Zhang JF; Sha ZJ; Zhu N; Huang XL; Li ZY
    Zhongguo Zhong Yao Za Zhi; 2021 May; 46(10):2392-2402. PubMed ID: 34047083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of Hanshi Zufei prescription for treatment of COVID-19 based on network pharmacology.
    Li X; Wen Z; Si M; Jia Y; Liu H; Zheng Y; Ma D
    Chin Herb Med; 2022 Apr; 14(2):294-302. PubMed ID: 35382000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Computational Intervention of Macrolide Antibiotics in the Treatment of COVID-19.
    Anwar F; Altayb HN; Al-Abbasi FA; Kumar V; Kamal MA
    Curr Pharm Des; 2021; 27(9):1202-1210. PubMed ID: 33550966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.